Home » Biosimilars Development Drives Generic-Drug Makers’ Partnerships
Biosimilars Development Drives Generic-Drug Makers’ Partnerships
Brand- and generic-drug makers continue to buddy up on biosimilars development with Baxter and Momenta Pharmaceuticals and Watson Pharmaceuticals and Amgen inking collaboration agreements.
Generic Line
Generic Line
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May